Peritoneal fluid contains high concentration of hepatocyte growth factor and vascular endothelial growth factor after resection for hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 862-865

  Hu, Rey Heng ^a   Ho, Ming Chih ^a   Wu, Yao Ming ^a   Lee, Po Huang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Ascites; Hepatectomy; Hepatocellular carcinoma; Hepatocyte growth factor, HGF; Vascular endothelial growth factor; VEGF

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; SCATTER FACTOR;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; PERITONEAL FLUID; PRIORITY JOURNAL;

ASCITIC FLUID; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; MALE; POSTOPERATIVE PERIOD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34250207648     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hu RH, Lee PH, You SC: Secretion of acute phase reactants before and after hepatocellular carcinoma resection. J Formosan Med Assoc 1999; 98:85-91.
2. Hu RH, Lee PH, Yu SC: Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma. Hepatogastroenterology 1999; 46:1842-1847.
3. Escobar E, Shimizu I, Mizobuchi Y, et al: Stimulation of albumin synthesis in rat hepatocyte by ascites from patients with cirrhosis. Tokushima J Experiment Med 1996; 43:159-166.
4. Luo JC, Yamaguchi S, Shinkai A, et al: Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors. Cancer Res 1998; 58:2652-2660.
5. Liu CD, Tilch L, Kwan D, et al: Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer. J Surg Res 2002; 102:31-34.
6. Cooper BC, Richie JM, Broghhammer CL, et al: Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res 2002; 8:3193-3197.
7. Yabushita H, Shimazu M, Noguchi M, et al: Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Oncol Reports 2003; 10:89-95.
8. Shimizu I, Ichihara A, Nakamura T: Hepatocyte growth factor in ascites from patients with cirrhosis. J Biochem 1991; 109:14-18.
9. Cejudo-Martin P, Ros J, Navasa M, et al: Increase production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2001; 34:487-493.
10. Zebroski BK, Liu W, Ramirez K, et al: Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol 1999; 6:373-378.
11. Stoecker B, Echtenacher B, Weich HA, et al: VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence. J Interferon Cytokine Res 2000; 20:511-517.
12. Akutagawa N, Nishikawa A, Iwasaki M, et al: Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model. Jpn J Cancer Res 2002; 93:644-651.
13. Sako A, Kitayama J, Yamaguchi H, et al: Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cells on the development of peritoneal metastasis. J Surg Res 2003; 115:113-120.
14. Li L, Wang L, Zhang W, et al: Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis, and patient survival in ovarian cancer. Anticancer Res 2004; 24:1973-1979.
15. Nascimento I, Schaer R, Lemaire D, et al: Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites. APMIS 2004; 112:585-587.
16. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M: Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001; 49:121-130.
17. Mochida S, Ishikawa K, Toshima K, et al: The mechanism of hepatocyte sinusoid endothelial ell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells. J Gastroenterol Hepatol 1998; 13:s1-5.
18. Gunsilius E, Gastl G: Platelets and VEGF blood levels in cancer patients. Br J Cancer 1999; 81:185-186.
19. Weltermann A, Wolzt M, Petersmann K, et al: Large amount of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. Arterioscleros Thromb Vasc Biol 1999; 19:1757-1760.
20. Jeng KS, Sheen IS, Wang YC, et al: Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study. World J Gastroenterol 2004; 10:643-648.
21. Zhao J, Hu J, and Cai J: Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma. Chin J Oncol 2001; 23:389-392.
22. Poon RT, Ng IO, Lau C, et al: Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 2001; 233:227-235.